Mendes, D., Alves, C., Afonso, N., Cardoso, F., Passos-Coelho, J. L., Costa, L., . . . Batel-Marques, F. (2015). The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review. Breast Cancer Res.
Citação norma ChicagoMendes, Diogo, Carlos Alves, Noémia Afonso, Fátima Cardoso, José Luís Passos-Coelho, Luís Costa, Sofia Andrade, and Francisco Batel-Marques. "The Benefit of HER2-targeted Therapies On Overall Survival of Patients With Metastatic HER2-positive Breast Cancer – a Systematic Review." Breast Cancer Res 2015.
MLA引文Mendes, Diogo, et al. "The Benefit of HER2-targeted Therapies On Overall Survival of Patients With Metastatic HER2-positive Breast Cancer – a Systematic Review." Breast Cancer Res 2015.